Ginzac, Angeline https://orcid.org/0000-0002-5614-0876
Bourbouloux, Emmanuelle
Rivoirard, Romain
Jouannaud, Christelle
Hager, Marie-Odile
Dubois, Sophie
Kwiatkowski, Fabrice https://orcid.org/0000-0002-4041-3999
Molnar, Ioana
Thivat, Emilie https://orcid.org/0000-0001-6833-1971
Durando, Xavier https://orcid.org/0000-0001-6035-3172
Funding for this research was provided by:
French National Cancer Institute and French Ministry of Health (PHRC-K13-170)
French National Cancer Institute and French Ministry of Health (PHRC-K13-170)
French National Cancer Institute and French Ministry of Health (PHRC-K13-170)
French National Cancer Institute and French Ministry of Health (PHRC-K13-170)
French National Cancer Institute and French Ministry of Health (PHRC-K13-170)
French National Cancer Institute and French Ministry of Health (PHRC-K13-170)
French National Cancer Institute and French Ministry of Health (PHRC-K13-170)
French National Cancer Institute and French Ministry of Health (PHRC-K13-170)
French National Cancer Institute and French Ministry of Health (PHRC-K13-170)
French National Cancer Institute and French Ministry of Health (PHRC-K13-170)
Article History
Received: 26 May 2025
Accepted: 9 December 2025
First Online: 20 December 2025
Declarations
:
: The study protocol was approved by the Sud-Est VI ethics committee (France) and by the French National Agency for the Safety of Medicines and Health Products (N° EudraCT: 2014-003505-14). All questionnaires, including the MMSE, were used with appropriate permissions following post hoc rectification with PAR.
: The authors declare no competing interests.
: All the procedures performed in the study, involving human participants, were in accordance with the ethical standards of the institutional and/or the national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethics standards.
: Written informed consent was obtained from all the participants included in the study.